[Performance characteristics of glycated albumin and its clinical usefulness in diabetic patients on hemodialysis].

Abstract

BACKGROUND The HbA1c has been considered to underestimate glucose level in diabetic patients on hemodialysis, therefore, glycated albumin (GA) was recently introduced to assess the glycemic control for those cases. We evaluated the performance of GA assay kit of Lucica GA-L (Asahi Kasei Pharma Co., Japan) and compare it with HbA1c for estimating glucose… (More)
DOI: 10.3343/kjlm.2009.29.5.406

3 Figures and Tables

Topics

  • Presentations referencing similar topics